Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
This is a support tool, not a standalone weight loss solution
Now, as I say, all of this for people who are definitely GLP one skeptics, I want you to know the goal is not just a smaller body, it's a strong body
Tirzepatide has also demonstrated superior efficacy compared to any other therapy used in the treatment of T2DM, comparable or superior even to regimes based on the use of multiple pharmacological classes
Gastrointestinal side effects lead some patients to discontinue treatment, and weight regain after stopping therapy is common
However, despite these promising findings, current evidence remains limited and heterogeneous
